Handa Pharmaceuticals Inc (ROCO:6620)
NT$ 69.6 1.1 (1.61%) Market Cap: 9.78 Bil Enterprise Value: 7.28 Bil PE Ratio: 21.75 PB Ratio: 3.38 GF Score: 63/100

Handa Pharmaceuticals Inc (ROCO:6620) Transcripts

    • 1